Organon Says Interim MIUDELLA Study Results Cover Six Years of Use
Organon said Sebela Women’s Health will present interim results from an ongoing Phase 3 study of its hormone-free copper IUD, MIUDELLA, through six years of use.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.